Sidoti Csr Forecasts Hawkins’ FY2026 Earnings (NASDAQ:HWKN)

Hawkins, Inc. (NASDAQ:HWKN) – Equities researchers at Sidoti Csr decreased their FY2026 EPS estimates for shares of Hawkins in a research report issued to clients and investors on Tuesday, February 3rd. Sidoti Csr analyst D. Harriman now anticipates that the specialty chemicals company will post earnings of $4.05 per share for the year, down from their previous estimate of $4.30. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. Sidoti Csr also issued estimates for Hawkins’ Q4 2026 earnings at $0.83 EPS, Q1 2027 earnings at $1.39 EPS, Q2 2027 earnings at $1.29 EPS, Q3 2027 earnings at $0.92 EPS, Q4 2027 earnings at $1.00 EPS, Q1 2028 earnings at $1.52 EPS and Q2 2028 earnings at $1.43 EPS.

Hawkins (NASDAQ:HWKN) last released its quarterly earnings data on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). The business had revenue of $244.08 million for the quarter, compared to the consensus estimate of $252.51 million. Hawkins had a net margin of 7.75% and a return on equity of 16.85%.

A number of other equities research analysts have also recently weighed in on the company. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. BWS Financial reiterated a “buy” rating and issued a $200.00 target price on shares of Hawkins in a report on Thursday, January 29th. Finally, Weiss Ratings lowered shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $162.50.

Hawkins Stock Up 2.0%

Hawkins stock opened at $129.28 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 2.35 and a debt-to-equity ratio of 0.49. The firm has a market cap of $2.70 billion, a P/E ratio of 32.73, a P/E/G ratio of 2.01 and a beta of 0.86. The business has a fifty day moving average of $144.47 and a two-hundred day moving average of $155.53. Hawkins has a twelve month low of $98.30 and a twelve month high of $186.15.

Hawkins Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be issued a $0.19 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is currently 19.24%.

Hedge Funds Weigh In On Hawkins

Several hedge funds have recently made changes to their positions in HWKN. Salomon & Ludwin LLC acquired a new stake in Hawkins during the 3rd quarter worth about $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in shares of Hawkins during the second quarter worth about $31,000. First Horizon Corp purchased a new stake in Hawkins in the third quarter valued at approximately $34,000. Sound Income Strategies LLC acquired a new position in Hawkins in the 4th quarter worth approximately $34,000. Finally, Aster Capital Management DIFC Ltd raised its position in Hawkins by 62.2% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock worth $55,000 after buying an additional 115 shares during the last quarter. 69.71% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Hawkins

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Hawkins announced a milestone for its WaterSurplus NanoStack membranes, a product development that supports revenue diversification in water-treatment solutions and could drive future sales growth and margin improvement. Hawkins, Inc. Announces Milestone for its WaterSurplus NanoStack Membranes
• Neutral Sentiment: A Zacks comparison piece examines Hawkins vs. Novozymes (NVZMY) for value investors. Coverage like this can increase investor attention and trading volume but doesn’t directly change fundamentals. NVZMY vs. HWKN: Which Stock Is the Better Value Option?
• Negative Sentiment: Sidoti Csr cut multiple near‑term EPS forecasts for Hawkins (Q4 2026, Q1–Q4 2027, Q1–Q2 2028 and FY2026), lowering its FY2026 view from $4.30 to $4.05 and trimming several quarter-level estimates — signalling softer near‑term earnings visibility. This analyst downdraft is a headwind for the stock until the company demonstrates consistent revenue/earnings upside. (Sidoti coverage reported via MarketBeat.) MarketBeat HWKN Coverage

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.